Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Current Assets (2021 - 2025)

Rxo's Current Assets history spans 5 years, with the latest figure at $1.3 billion for Q4 2025.

  • For Q4 2025, Current Assets fell 1.64% year-over-year to $1.3 billion; the TTM value through Dec 2025 reached $1.3 billion, down 1.64%, while the annual FY2025 figure was $1.3 billion, 1.64% down from the prior year.
  • Current Assets reached $1.3 billion in Q4 2025 per RXO's latest filing, up from $1.2 billion in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $1.3 billion in Q4 2024 to a low of $770.0 million in Q1 2024.
  • Average Current Assets over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2021.
  • The largest YoY upside for Current Assets was 68.22% in 2024 against a maximum downside of 25.17% in 2024.
  • A 5-year view of Current Assets shows it stood at $1.1 billion in 2021, then dropped by 4.99% to $1.0 billion in 2022, then decreased by 22.64% to $796.0 million in 2023, then surged by 68.22% to $1.3 billion in 2024, then decreased by 1.64% to $1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for RXO's Current Assets are $1.3 billion (Q4 2025), $1.2 billion (Q3 2025), and $1.2 billion (Q2 2025).